Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.
about
Kainic acid-induced neurodegenerative model: potentials and limitationsLack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout miceInfluence of pentylenetetrazol and NF-κB decoy oligodeoxynucleotides on p38 expression in neuron-like cells.Contrasting features of ERK1/2 activity and synapsin I phosphorylation at the ERK1/2-dependent site in the rat brain in status epilepticus induced by kainic acid in vivo.Regulation of ERK1/2 mitogen-activated protein kinase by NMDA-receptor-induced seizure activity in cortical slicesEffects of valproate sodium on extracellular signal-regulated kinase 1/2 phosphorylation following hippocampal neuronal epileptiform discharge in rats.Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.Influences of the circadian clock on neuronal susceptibility to excitotoxicity.Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 bindingNeuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms.
P2860
Q34355569-2FD5676A-2C1C-46BF-8BB3-C70ECBDE1971Q34699394-F8A2C807-F233-42AE-850A-3E75B9430340Q35204215-9B0E7229-E4BF-42EE-A857-1CAA7AD7AA69Q36260373-2C366C52-1A56-4D15-ABF5-4223A91D0A6EQ36828376-692945CB-D797-422D-82B0-4FF2672BCF83Q37313136-A0A4C8BC-58F2-4DD5-AEB4-535BABA01EF3Q38023551-0B709861-F7A5-4A6B-830A-1F13045C0E7AQ38160842-D4840ADD-6831-4464-95B5-1982CC8F4D09Q38274565-8E8C7A8A-1DD5-463F-99A4-B0F28C49E7EAQ48197598-ABF242B0-3E02-40D8-8603-C5E3FD05CC4A
P2860
Differences in activation of ERK1/2 and p38 kinase in Jnk3 null mice following KA treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Differences in activation of E ...... l mice following KA treatment.
@en
Differences in activation of E ...... l mice following KA treatment.
@nl
type
label
Differences in activation of E ...... l mice following KA treatment.
@en
Differences in activation of E ...... l mice following KA treatment.
@nl
prefLabel
Differences in activation of E ...... l mice following KA treatment.
@en
Differences in activation of E ...... l mice following KA treatment.
@nl
P2093
P50
P1476
Differences in activation of E ...... ll mice following KA treatment
@en
P2093
Carme Auladell
Ester Verdaguer
Isisdre Ferrer
Luisa de Lemos
Rafael Romero
P2860
P304
P356
10.1111/J.1471-4159.2010.06853.X
P407
P577
2010-06-08T00:00:00Z